home - Maps & Directions - Institute of Child Health
 

Notice Board Topics

Archive workshop and seminar slides Professor Peter Karmerman…
Wellcome Trust conference The Challenges of Chronic Pain

11-13 March 2015
Wellcome Trust Genome Campus, Hinxton, Cambridge, UK

Abstract deadline: 30 January 2015
Registration deadline: 16 February 2015

For more information
click here

Europain consortium receives EU and industry funding and begins five year research into better treatments for chronic pain Europain, a public-private consortium funded by the Innovative Medicines Initiative (IMI), announced today the launch of a five-year research project to understand and improve treatment of chronic pain. The project will receive 6M€ from the IMI as well as 12.5M€ in kind contribution from the European Federation of Pharmaceutical Industries and Associations (EFPIA) over the coming five years.

One in five adults suffers from chronic pain. This constitutes a major cause of long-term sick leave and forced early retirement, placing a great financial burden on both individuals and healthcare systems. Despite extensive research programmes by biopharmaceutical companies and academia, there remains a need for treatments that are more effective and with fewer side-effects.

Europain has established an international team of leading researchers and clinicians from both academia and industry to undertake multidisciplinary translational research. This team aims to increase the understanding of chronic pain mechanisms, help to develop novel analgesics, and develop better biomarkers for pain. Their ultimate goal is to improve the lives of people suffering from chronic pain.

During the five-year project, Europain will undertake a large number of preclinical and clinical studies. The program will be delivered through collaboration between laboratories in the Europain network, sharing resources to improve the value derived from the budget. Results will be made public during and after the project, ensuring that the knowledge created can be widely applied to the development of better therapies for patients suffering from chronic pain.

King’s College London, the managing entity of Europain and the academic lead institution will contribute to both the pre-clinical and clinical aspects of the project. One role will be to study the expression of potential pain mediators in both animal models of pain and samples from patients suffering from chronic pain. The role of novel pain mediators will then be investigated using an array of techniques ranging from cell culture to quantitative sensory testing in humans.

Professor Steve McMahon, who along with Dr Dave Bennett will be running the project at King’s, comments: ‘There are some big questions facing the pain field at the moment and this consortium, drawing on the skills and expertise of both academia and industry, is in a unique position to address them’.

The consortium network involves scientists representing 12 renowned European Universities: King’s College London (Academic lead), University College London, Imperial College London, the University of Oxford, the Christian-Albrechts-University of Kiel, the Medical Faculty Mannheim/Heidelberg University, the Technische Universität München, the Goethe University of Frankfurt, the BG University Hospital Bergmannsheil/Ruhr University Bochum, the University Hospitals of Aarhus, Rigshospitalet Copenhagen, University of Southern Denmark, the SME Neuroscience Technologies from Barcelona, and the research resources and expertise of Europe’s most active pharmaceutical companies working in the field of analgesics, including AstraZeneca (co-ordinator), Boehringer-Ingelheim, Eli Lilly, Esteve, Pfizer, Sanofi-Aventis, UCB Pharma.

About the Innovative Medicines Initiative

IMI is a unique Public-Private Partnership (PPP) between the pharmaceutical industry represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Union represented by the European Commission.
www.imi.europa.eu.
 
Institute of Child Health
(Koltzenburg)

Institute of Child Health
University College London
30 Guilford Street
London WC1N 1EH

By Car
Street map
Congestion charge

By Bus
Russell Square no. 59, 68,91, 168, X68, 188
Gray's Inn Road no. 17,45, 46

Bus

By Underground
Russell Square-Piccadilly Line
Holborn-Central and Piccadilly line
King's Cross-Northern, Victoria, Hammersmith & City, Bakerloo, Piccadilly & Circle

Underground

By Train
Euston within walking distance or bus
Charing Cross-Northern Line to Leicester Square, Piccadilly Line to Russell Square
King's Cross and St Pancras within walking distance or bus 45, 46
Liverpool Street-Central line to Holborn
London Bridge-Northern Line to Bank, Central Line to Holborn, bus 243 (towards Wood Green)
Marylebone-Bakerloo line to Oxford Circus, Central line to Holborn
Moorgate-Hammersmith & City, Circle, Metropolitan line or Northern to King's Cross
Paddington-Hammersmith & City line to King's Cross, Piccadilly line to Russell Square
Victoria-Victoria line to King's Cross
Waterloo-Bus 59 (towards Euston),1 (towards Tottenham Court Road), 188 (towards Bedford Place/Russell Square), 171 (Holborn)

National Rail
Underground

By Air
Heathrow, Stanstead, Gatwick airports offer convenient public transport links to Central London.

City
Gatwick
Heathrow
Stansted